nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AALL0434 Treatment Therapy Has Excellent Outcomes in Children With T-ALL
|
Vinall, Maria |
|
2014 |
|
55 |
p. 5-6 |
artikel |
2 |
Activity of Lenalidomide in MDS Tied to Degradation of CSNK1A1
|
Vinall, Maria |
|
2014 |
|
55 |
p. 7-8 |
artikel |
3 |
Advances and Challenges in Sickle Cell Anemia
|
Hoyle, Brian |
|
2014 |
|
55 |
p. 2-3 |
artikel |
4 |
American Society of Hematology, 56th Annual Meeting & Exposition: Advisors’ Introduction
|
Connors, Jean M. |
|
2014 |
|
55 |
p. ii-ii |
artikel |
5 |
ASCT for Multiple Myeloma: The Role of the Novel Agents
|
Hitt Nichols, Emma |
|
2014 |
|
55 |
p. 31-33 |
artikel |
6 |
AZA Plus LEN or VOR Do Not Improve Response Rates in MDS or CMML, Though DFS and OS Still an Open Question
|
Lederman, Lynne |
|
2014 |
|
55 |
p. 13-14 |
artikel |
7 |
Benefit of Extended Anticoagulation After Unprovoked PE Lost After Treatment Discontinuation
|
Lederman, Lynne |
|
2014 |
|
55 |
p. 11-11 |
artikel |
8 |
CKT Implicated in Worse Outcomes With Ibrutinib Therapy of CLL
|
Hoyle, Brian |
|
2014 |
|
55 |
p. 16-17 |
artikel |
9 |
Clonal Mapping of Hematopoiesis In Vivo Provides Direction for New Clinical Protocols
|
Vinall, Maria |
|
2014 |
|
55 |
p. 6-6 |
artikel |
10 |
Coagulation Therapy and Thrombosis
|
Hoyle, Brian |
|
2014 |
|
55 |
p. 23-25 |
artikel |
11 |
Dasatinib Outcomes Maintained Over 5 Years
|
Hitt Nichols, Emma |
|
2014 |
|
55 |
p. 19-20 |
artikel |
12 |
FCR Superior in Treatment of Advanced CLL
|
Hoyle, Brian |
|
2014 |
|
55 |
p. 16-16 |
artikel |
13 |
4F-PCC Reverses Apixaban Anticoagulation in Healthy Volunteers
|
Hitt Nichols, Emma |
|
2014 |
|
55 |
p. 21-21 |
artikel |
14 |
FXI-ASO May Represent a New Class of Antithrombotic Agents
|
Lederman, Lynne |
|
2014 |
|
55 |
p. 10-10 |
artikel |
15 |
Idarucizumab Reverses Dabigatran in Elderly or Renally Impaired
|
Hitt Nichols, Emma |
|
2014 |
|
55 |
p. 14-15 |
artikel |
16 |
Insights Into Pathophysiology of Lymphomas Help Identify Therapeutic Targets
|
Kuznar, Wayne |
|
2014 |
|
55 |
p. 26-27 |
artikel |
17 |
JAK2-STAT3 Signaling Implicated in the Regulation of Hepatic TPO Production
|
Vinall, Maria |
|
2014 |
|
55 |
p. 4-5 |
artikel |
18 |
MRD and Clinical Response Predictors of PFS in CLL
|
Hoyle, Brian |
|
2014 |
|
55 |
p. 17-18 |
artikel |
19 |
Noninvasive Detection of Genomic Imbalances in HL Is Promising
|
Lederman, Lynne |
|
2014 |
|
55 |
p. 18-19 |
artikel |
20 |
PCC Reverses Dabigatran-Associated Bleeding in Polytrauma Model
|
Hitt Nichols, Emma |
|
2014 |
|
55 |
p. 22-22 |
artikel |
21 |
Reduced-Dose Conditioning Comparable to Standard Dose Prior to ASCT in MDS
|
Hitt Nichols, Emma |
|
2014 |
|
55 |
p. 20-21 |
artikel |
22 |
Sorafenib as Effective Treatment for Newly Diagnosed AML in Younger Patients
|
Vinall, Maria |
|
2014 |
|
55 |
p. 8-9 |
artikel |
23 |
Th17-Prone CD146+CCR5+ T-Cell Population Is an Early Marker of Intestinal GVHD
|
Vinall, Maria |
|
2014 |
|
55 |
p. 8-8 |
artikel |
24 |
Tinzaparin Reduces the Risk of Recurrent Thromboembolic Events in Patients With Cancer
|
Lederman, Lynne |
|
2014 |
|
55 |
p. 12-12 |
artikel |
25 |
Treatment Paradigms for MPNs Continue to Evolve
|
Kuznar, Wayne |
|
2014 |
|
55 |
p. 28-30 |
artikel |
26 |
Vosaroxin in Combination With Cytarabine Provides a New Salvage Option for AML
|
Lederman, Lynne |
|
2014 |
|
55 |
p. 15-16 |
artikel |